A new study from the University of Cologne claims that leucine mitochondrial energy production is connected through a previously uncharacterised mechanism: the amino acid appears to protect key proteins on the outer surface of mitochondria from being broken down, allowing cells to generate more energy when nutrients are plentiful. The findings, published in Nature Cell Biology (volume 27, pages 1889–1901), open a potential new avenue for research into metabolic disorders and cancer, though the authors are careful to flag the risks of intervening in the pathway.
What the leucine mitochondrial energy production study actually shows
Mitochondria adjust their activity continuously depending on how much energy a cell needs and which nutrients are available. Scientists have long known that nutrition can influence this process; what has been less clear is how individual nutrients send the relevant signals. The Cologne team, led by Professor Dr. Thorsten Hoppe of the Institute for Genetics and the CECAD Cluster of Excellence on Ageing Research, says leucine does more than contribute to protein synthesis. It also suppresses the degradation of proteins on the mitochondrial outer membrane, which in turn allows those organelles to run more efficiently.
The mechanism the researchers describe centres on a protein called SEL1L, which is part of the cell’s quality-control machinery. Cells routinely identify and destroy damaged or misfolded proteins, and SEL1L directs proteins earmarked for removal towards degradation. According to the study, leucine appears to reduce SEL1L activity, meaning fewer mitochondrial membrane proteins are broken down and more remain in place to support energy production.
Crucially, the researchers describe this as a three-part axis. According to PubMed, the study defines a leucine-GCN2-SEL1L axis that links nutrient sensing directly to mitochondrial proteostasis, the process by which cells maintain a balanced, functional protein population in their mitochondria. That framing is more precise than a simple claim that leucine “protects” proteins: it places the amino acid inside a signalling chain with at least two identified intermediaries.
The evidence and what it cannot yet support
The first author, Dr. Qiaochu Li, is quoted as saying: ‘We were thrilled to discover that a cell’s nutrient status, especially its leucine levels, directly impacts energy production. This mechanism enables cells to swiftly adapt to increased energy demands during periods of nutrient abundance.’ That is a plausible and interesting claim, but it is worth noting that the study describes a mechanism, not a clinical intervention. The distance from a cellular mechanism to a treatment for metabolic disorders is long, and the authors acknowledge it.
Li is also quoted on the risks: ‘Modulating leucine and SEL1L levels could be a strategy to boost energy production. However, it is important to proceed with caution. SEL1L also plays a crucial role in preventing the accumulation of damaged proteins, which is essential for long-term cellular health.’ In short, the very system that leucine appears to suppress is also responsible for clearing out defective proteins. Dialling it down in the hope of boosting mitochondrial output could, in principle, allow damaged proteins to accumulate. The researchers have identified a mechanism; they have not resolved that tension.
The team also worked with Caenorhabditis elegans, the roundworm routinely used in cell biology because many of its cellular processes parallel those in more complex organisms. According to EurekAlert!, defects in leucine breakdown disrupted mitochondrial function in the worms and were linked to fertility problems, which widens the potential relevance of the pathway beyond energy metabolism alone. The researchers also examined human lung cancer cells and found that certain mutations affecting leucine metabolism could help cancer cells survive, an observation the authors say could matter for future cancer research because treatments targeting leucine-related pathways may affect healthy and tumour cells differently.
What the study does not do is provide direct evidence that eating more leucine-rich food (dairy, meat, beans, lentils, per the paper) will meaningfully change mitochondrial function in healthy adults. The mechanism was characterised at the cellular and model-organism level. Whether the leucine-GCN2-SEL1L axis behaves the same way in human physiology at scale is, for now, an open question the paper does not claim to answer.
The work was supported by Germany’s Excellence Strategy through CECAD, several Collaborative Research Centres funded by the German Research Foundation (DFG), the European Research Council via the ERC Advanced Grant ‘CellularPQCD’, and the Alexander von Humboldt Foundation. The full paper, ‘Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration,’ is available in Nature Cell Biology, volume 27, pages 1889–1901, with the DOI 10.1038/s41556-025-01799-3.
